MetLife, Inc. (MET) and Primerica, Inc. (PRI) both operate in the insurance and financial services space, yet they serve very different markets and have produced sharply different relative performance in recent months. MetLife is a global insurance and asset management giant, while Primerica is a focused distributor of term life insurance and investment products to middle-income North American households. This stock comparison is most relevant for investors weighing scale and diversification against a leaner, higher-margin distribution model, as well as for traders assessing momentum, trend quality, and market positioning.
MetLife is one of the world's largest insurers, with a diversified footprint spanning Group Benefits, Retirement and Income Solutions, Asia, Latin America, and EMEA (Europe, the Middle East, and Africa), alongside its MetLife Investment Management arm. In its most recent reported quarter, MET posted adjusted operating earnings per share (EPS) of $2.42, up roughly 23% year over year, supported by higher net investment income, favorable underwriting, and solid volume growth. Adjusted return on equity (ROE, a measure of profitability relative to shareholders' capital) reached about 17%.
Recent market activity has favored the stock. MetLife shares have advanced sharply over the course of the year, with several reports noting a year-to-date gain exceeding 20% and a strong relative outperformance against the broader insurance sector. Analyst sentiment has remained constructive, with a consensus "Buy" rating and price targets that have generally trended higher in recent weeks. Catalysts include continued execution of the company's "New Frontier" expense and growth program, a new multi-billion-dollar share repurchase authorization, and strength in Group Benefits underwriting.
Primerica is a financial services distribution company headquartered in Duluth, Georgia, focused on middle-income households in the United States and Canada. Its model combines term life insurance with a large independent sales force that also distributes mutual funds, managed accounts, variable annuities, and other products. In its most recent reported quarter, PRI delivered adjusted operating EPS of $5.96, up 19% year over year, while adjusted operating revenues rose about 9%. Growth was led by its Investment and Savings Products (ISP) segment, which reached record sales of $4.3 billion and drove client asset values to roughly $127 billion.
However, recent performance has been more mixed. Term life policies issued declined by a double-digit percentage as cost-of-living pressures weighed on younger, middle-income buyers, and the company's life-licensed sales force contracted slightly. In the market, PRI has lagged, with a more modest year-to-date gain and notable weakness over the trailing three-month period. The stock's risk-based capital (RBC) ratio — a regulatory measure of an insurer's financial strength — remained robust at an estimated 430%, underscoring a sound balance sheet even amid softer distribution momentum.
Tickeron's Trending AI Robots page curates a selection of automated trading strategies from a much larger universe of AI trading bots that collectively monitor thousands of tickers. Because market conditions shift constantly, not every bot is well-suited to the current environment, so this section highlights only the strategies that have demonstrated the strongest alignment with prevailing trends and volatility. The available bots span a wide range of trading styles, timeframes, risk profiles, performance statistics, and underlying ticker sets, giving traders a broad menu of quantitative approaches to evaluate. For investors seeking a data-driven edge in comparisons like this one, reviewing Trending AI Robots offers a practical way to see which automated strategies are currently gaining traction.
The clearest contrast between these two names is scale versus focus. MetLife operates a global, multi-line business with substantial institutional and international exposure, while Primerica runs a capital-light distribution model concentrated on North American middle-income households. Growth drivers differ accordingly: MET benefits from rising investment income, strong group underwriting, and international volume growth, whereas PRI leans on record ISP sales and demographic tailwinds in retirement savings, offset by softer life insurance issuance.
Momentum also diverges. MetLife has sustained a stronger uptrend and received predominantly bullish analyst revisions in recent weeks, while Primerica has encountered more tempered ratings action and a pullback in its share price despite solid fundamentals. On valuation, Primerica trades at a lower price-to-earnings multiple relative to MetLife, but its near-term earnings trajectory is more sensitive to distribution productivity and middle-income consumer pressures. Risk profiles differ as well: MetLife carries broader market and credit exposure across its investment portfolio, while Primerica's concentrated reliance on its sales force and investment product flows represents a distinct operational risk.
Based on observable trend consistency, relative momentum, earnings strength, and analyst positioning, Tickeron's AI would currently favor MET over PRI. MetLife's more durable upward trajectory, broad-based segment performance, and increasingly favorable analyst revisions give it a stronger technical and fundamental profile in the current environment. Primerica remains a well-capitalized, profitable franchise with an attractive growth engine in investment products, but softer term-life trends and recent price weakness suggest its near-term setup carries greater uncertainty. This assessment is probabilistic and reflects current conditions rather than a fixed conclusion.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where MET advanced for three days, in 229 of 346 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 34 of 55 cases where MET's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 62%.
The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on MET as a result. In 45 of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 54%.
The Moving Average Convergence Divergence (MACD) for MET just turned positive on November 10, 2026. Looking at past instances where MET's MACD turned positive, the stock continued to rise in 32 of 53 cases over the following month. The odds of a continued upward trend are 60%.
MET moved above its 50-day moving average on October 08, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for MET crossed bullishly above the 50-day moving average on October 13, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 60%.
The Aroon Indicator entered an Uptrend today. In 153 of 283 cases where MET Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 54%.
The 10-day RSI Indicator for MET moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 47 similar instances where the indicator moved out of overbought territory. In 20 of the 47 cases, the stock moved lower in the following days. This puts the odds of a move lower at 43%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MET declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 51%.
MET broke above its upper Bollinger Band on October 12, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 20 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 24 (best 1 - 100 worst), indicating outstanding price growth. MET’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 55 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: MET's P/B Ratio (2.276) is slightly higher than the industry average of (1.337). P/E Ratio (18.683) is within average values for comparable stocks, (19.773). Projected Growth (PEG Ratio) (0.506) is also within normal values, averaging (0.463). Dividend Yield (0.024) settles around the average of (0.047) among similar stocks. P/S Ratio (0.824) is also within normal values, averaging (1.303).
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
PRI moved above its 50-day moving average on November 04, 2026 date and that indicates a change from a downward trend to an upward trend. In 33 of 47 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 70%.
The Momentum Indicator moved above the 0 level on November 05, 2026. You may want to consider a long position or call options on PRI as a result. In 55 of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 62%.
The 10-day moving average for PRI crossed bullishly above the 50-day moving average on November 09, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 68%.
Following a +4.66% 3-day Advance, the price is estimated to grow further. Considering data from situations where PRI advanced for three days, in 208 of 336 cases, the price rose further within the following month. The odds of a continued upward trend are 62%.
The Aroon Indicator entered an Uptrend today. In 210 of 347 cases where PRI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 61%.
The 10-day RSI Indicator for PRI moved out of overbought territory on November 11, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 41 similar instances where the indicator moved out of overbought territory. In 27 of the 41 cases, the stock moved lower in the following days. This puts the odds of a move lower at 66%.
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
PRI broke above its upper Bollinger Band on November 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Profit vs. Risk Rating rating for this company is 14 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock better than average.
The Tickeron SMR rating for this company is 33 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 44 (best 1 - 100 worst), indicating steady price growth. PRI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 45 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 73 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: PRI's P/B Ratio (3.545) is very high in comparison to the industry average of (1.337). P/E Ratio (11.661) is within average values for comparable stocks, (19.773). Projected Growth (PEG Ratio) (0.540) is also within normal values, averaging (0.463). Dividend Yield (0.017) settles around the average of (0.047) among similar stocks. PRI's P/S Ratio (2.710) is slightly higher than the industry average of (1.303).
MET | PRI | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 29 | 46 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 55 Fair valued | 73 Overvalued | |
PROFIT vs RISK RATING 1..100 | 20 | 14 | |
SMR RATING 1..100 | 99 | 33 | |
PRICE GROWTH RATING 1..100 | 24 | 44 | |
P/E GROWTH RATING 1..100 | 15 | 45 | |
SEASONALITY SCORE 1..100 | 50 | 65 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
MET's Valuation (55) in the Life Or Health Insurance industry is in the same range as PRI (73). This means that MET’s stock grew similarly to PRI’s over the last 12 months.
PRI's Profit vs Risk Rating (14) in the Life Or Health Insurance industry is in the same range as MET (20). This means that PRI’s stock grew similarly to MET’s over the last 12 months.
PRI's SMR Rating (33) in the Life Or Health Insurance industry is significantly better than the same rating for MET (99). This means that PRI’s stock grew significantly faster than MET’s over the last 12 months.
MET's Price Growth Rating (24) in the Life Or Health Insurance industry is in the same range as PRI (44). This means that MET’s stock grew similarly to PRI’s over the last 12 months.
MET's P/E Growth Rating (15) in the Life Or Health Insurance industry is in the same range as PRI (45). This means that MET’s stock grew similarly to PRI’s over the last 12 months.
| MET | PRI | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 43% | 1 day ago 66% |
| Stochastic ODDS (%) | 1 day ago 62% | 1 day ago 52% |
| Momentum ODDS (%) | 1 day ago 54% | 1 day ago 63% |
| MACD ODDS (%) | 1 day ago 60% | N/A |
| TrendWeek ODDS (%) | 1 day ago 61% | 1 day ago 63% |
| TrendMonth ODDS (%) | 1 day ago 54% | 1 day ago 61% |
| Advances ODDS (%) | 1 day ago 66% | 2 days ago 62% |
| Declines ODDS (%) | 6 days ago 51% | N/A |
| BollingerBands ODDS (%) | 1 day ago 47% | 1 day ago 48% |
| Aroon ODDS (%) | 1 day ago 54% | 1 day ago 61% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
MET’s FA Score shows that 3 FA rating(s) are green while PRI’s FA Score has 2 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
MET’s TA Score shows that 7 TA indicator(s) are bullish while PRI’s TA Score has 6 bullish TA indicator(s).
MET (@Life/Health Insurance) experienced а +0.05% price change this week, while PRI (@Life/Health Insurance) price change was +8.53% for the same time period.
The average weekly price growth across all stocks in the @Life/Health Insurance industry was +0.56%. For the same industry, the average monthly price growth was +3.48%, and the average quarterly price growth was -0.70%.
MET is expected to report earnings on Feb 03, 2027.
PRI is expected to report earnings on Feb 16, 2027.
Life insurance companies mainly sell policies that pay a death benefit as a lump sum upon the death of the insured to their beneficiaries. Life insurance policies may be sold as term life, (which guarantees payment of a stated death benefit and expires at the end of a specified term) or permanent /typically whole life (which is more expensive but lasts a lifetime and carries a cash accumulation component). Life insurance firms may also sell long-term disability policies that help to replace the insured individual’s income if they become sick or disabled. Health insurance, on the other hand, helps pay for medical expenses. Anthem, Inc., MetLife, Inc. and Aflac Incorporated are some of the largest U.S. companies in this industry.
A.I.dvisor indicates that over the last year, MET has been closely correlated with PRU. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if MET jumps, then PRU could also see price increases.
A.I.dvisor indicates that over the last year, PRI has been loosely correlated with MET. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if PRI jumps, then MET could also see price increases.